Savage Brian
Interim Chief Legal Officer
Savage Brian has filed 3 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Mar 9, 2026.
On the most recent filing, Savage Brian is listed as Interim Chief Legal Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD. Inside the rolling window, Savage Brian reported no open-market purchases and 3 open-market sales totaling $164K in TEVA. The largest disclosed transaction in the window is a sale of 2,675 TEVA shares on Mar 4, 2026, worth $87K.
Companies traded
Other insiders at TEVA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$164K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Savage Brian made?
Savage Brian has filed 3 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.
Which companies does Savage Brian trade?
Savage Brian has filed SEC Form 4 disclosures for 1 company, including TEVA.
When was Savage Brian's most recent SEC Form 4 filing?
Savage Brian's most recent SEC Form 4 filing on Tracefour is dated Mar 9, 2026.
What is Savage Brian's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Savage Brian is listed as Interim Chief Legal Officer.
What is Savage Brian's total buy and sell value in the current window?
Inside the rolling retention window, Savage Brian bought $0 and sold $164K based on SEC Form 4 filings.
What was Savage Brian's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,675 TEVA shares on 2026-03-04, worth $87K, per SEC Form 4 filings.